Back to Neuberger Berman Group LLC Neuberger Berman Group LLC

ASND

15 quarters

Position history for Neuberger Berman Group LLCNeuberger Berman Group LLC's holdings in Ascendis Pharma A/S

Yes. Neuberger Berman holds 142,705 shares of ASND (Ascendis Pharma), worth $38.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$38.1M

Current Shares

142,705

Total Value Change

+$29.1M

Total Shares Change

+78,036

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
142,705
-
$38.1M0.0%$266.72
40
2025-Q4
Exited
0
-100.0%
$00.0%$213.24
0
2025-Q3
Decreased
21,049
-9.4%
$4.2M0.0%$198.81
0
2025-Q2
Decreased
23,234
-49.9%
$4M0.0%$172.60
0
2025-Q1
Increased
46,330
+21.5%
$7.2M0.0%$155.86
33
2024-Q4
Decreased
38,129
-4.1%
$5.2M0.0%$137.67
0
2024-Q3
Increased
39,762
+31.3%
$5.9M0.0%$149.31
34
2024-Q2
New
30,296
-
$4.1M0.0%$136.38
37
2021-Q2
Exited
0
-100.0%
$00.0%$131.55
0
2021-Q1
Increased
190,900
+46.3%
$24.6M0.0%$128.88
39
2020-Q4
Increased
130,500
+1.9%
$21.8M0.0%$166.78
29
2020-Q3
Increased
128,000
+20.8%
$19.8M0.0%$154.32
34
2020-Q2
Increased
106,000
+78.2%
$15.7M0.0%$147.90
43
2020-Q1
Decreased
59,500
-8.0%
$6.7M0.0%$112.61
0
2019-Q4
New
64,669
-
$9M0.0%$139.12
38

Other major holders of ASND: RA Capital Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used